2019
Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease
Balbuena-Merle R, Hendrickson JE. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Transfusion Clinique Et Biologique 2019, 26: 112-115. PMID: 30857806, DOI: 10.1016/j.tracli.2019.02.003.Peer-Reviewed Original ResearchConceptsHemolytic transfusion reactionsSickle cell diseaseRed blood cell alloimmunizationRBC alloantibodiesTransfusion reactionsRBC alloimmunizationCell diseaseLife-threatening hemolytic transfusion reactionsSubset of patientsBlood bank testingCurrent screening practicesAlternative complement pathwayRBC autoantibodiesTransfusion burdenInflammatory statusPatient populationCase reportRBC exposureBlood donorsScreening practicesHigh prevalenceChronic hemolysisAlloantibodiesBystander hemolysisPatients
2018
Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature
Russo A, Curtis S, Balbuena-Merle R, Wadia R, Wong E, Chao HH. Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature. Experimental Hematology & Oncology 2018, 7: 15. PMID: 29989046, PMCID: PMC6035443, DOI: 10.1186/s40164-018-0108-7.BooksLow molecular weight heparinBullous hemorrhagic dermatosisWeight heparinCoagulation testingFull-dose low molecular weight heparinMajority of patientsSmall case seriesMolecular weight heparinDays of administrationSearch of PubMedSite of injectionCase seriesIntracranial hemorrhageOvid EmbaseCase reportElderly menLate diagnosisTherapeutic rangeOvid MEDLINEAnticoagulationSide effectsPatientsTherapeutic interventionsNew casesDifferent anticoagulants